January 24, 2018 Celgene’s $9B Buyout of Juno to Boost Company’s Immuno-Oncology Portfolio News Celgene says it will buy Juno Therapeutics for $9 billion in a deal that could make Celgene a world leader in immuno-oncology treatments. ... Read more